Activity
-
There are only two weeks left to sign up for our September 19 webinar in conjunction with SpringerNature, titled “Gene Therapy Research: Pitfalls and…
There are only two weeks left to sign up for our September 19 webinar in conjunction with SpringerNature, titled “Gene Therapy Research: Pitfalls and…
Shared by Karen Stams
-
How is ML-enabled Cryo-EM elevating LNP characterization to highly accurate quantitative results from statistically relevant sample sizes?…
How is ML-enabled Cryo-EM elevating LNP characterization to highly accurate quantitative results from statistically relevant sample sizes?…
Shared by Karen Stams
-
ISSX and JSSX would like to thank Charles River for being a silver sponsor at the upcoming ISSX/JSSX 2024 Meeting to be held in Honolulu, Hawaii…
ISSX and JSSX would like to thank Charles River for being a silver sponsor at the upcoming ISSX/JSSX 2024 Meeting to be held in Honolulu, Hawaii…
Liked by Karen Stams
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
More activity by Karen
-
It's always an honor to see a project you worked on go the distance to approval, but this one is special. https://lnkd.in/ezEWUHwk
It's always an honor to see a project you worked on go the distance to approval, but this one is special. https://lnkd.in/ezEWUHwk
Liked by Karen Stams
-
Positive collaboration ensures success for your #drugdevelopment program. Learn how our #Kansas facility reduces your development timelines and…
Positive collaboration ensures success for your #drugdevelopment program. Learn how our #Kansas facility reduces your development timelines and…
Liked by Karen Stams
-
It's time to celebrate! Our small molecule drug discovery team has just celebrated co-filing 500 patents! This incredible achievement is a testament…
It's time to celebrate! Our small molecule drug discovery team has just celebrated co-filing 500 patents! This incredible achievement is a testament…
Liked by Karen Stams
-
Here's the latest from the people @ No Patient Left Behind. They're working to lower (or eliminate) the high co-pays and out-of-pocket costs…
Here's the latest from the people @ No Patient Left Behind. They're working to lower (or eliminate) the high co-pays and out-of-pocket costs…
Liked by Karen Stams
-
Hoping Jango doesn’t notice I’m a day late on International Dog Day appreciation post. From our college days at Amherst (peep the puppy pic) to our…
Hoping Jango doesn’t notice I’m a day late on International Dog Day appreciation post. From our college days at Amherst (peep the puppy pic) to our…
Liked by Karen Stams
-
We’re excited to be a part of this year’s CAR-TCR Summit Series taking place on September 17-20 in Boston, MA! Schedule a meeting with us or stop…
We’re excited to be a part of this year’s CAR-TCR Summit Series taking place on September 17-20 in Boston, MA! Schedule a meeting with us or stop…
Shared by Karen Stams
-
We are excited to welcome Dr. Dean Brown to the Drug Hunter Scientific Advisory Board! Dr. Brown brings over 25 years of experience in industry in…
We are excited to welcome Dr. Dean Brown to the Drug Hunter Scientific Advisory Board! Dr. Brown brings over 25 years of experience in industry in…
Liked by Karen Stams
-
Join us at the 2024 ISSX/JSSX meeting in Honolulu, Hawaii from September 15-18 and make sure to attend our presentation on in vitro CNS permeability…
Join us at the 2024 ISSX/JSSX meeting in Honolulu, Hawaii from September 15-18 and make sure to attend our presentation on in vitro CNS permeability…
Shared by Karen Stams
-
Shaping the future together: Udo Merbold, Group Leader Downstream Processing at Miltenyi Biotec, takes you through the journey of collaboration with…
Shaping the future together: Udo Merbold, Group Leader Downstream Processing at Miltenyi Biotec, takes you through the journey of collaboration with…
Shared by Karen Stams
-
There’s a leaner strategic approach to anti-drug antibody (ADA) assessments to support nonclinical #toxicology studies. In this session expert…
There’s a leaner strategic approach to anti-drug antibody (ADA) assessments to support nonclinical #toxicology studies. In this session expert…
Shared by Karen Stams
-
“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the…
“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the…
Shared by Karen Stams
-
Featured in Genetic Engineering & Biotechnology News: Creating Consistency and Confidence for Biopharma Companies https://okt.to/CXvEgo…
Featured in Genetic Engineering & Biotechnology News: Creating Consistency and Confidence for Biopharma Companies https://okt.to/CXvEgo…
Shared by Karen Stams
-
Gain insights into how the fitness and function of CAR T cells may depend on how they are cryopreserved and shipped. Register now to discover a novel…
Gain insights into how the fitness and function of CAR T cells may depend on how they are cryopreserved and shipped. Register now to discover a novel…
Shared by Karen Stams
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More